We are partnering with @CancerResrch on their newly launched Digital PATH Project, which will identify factors that may contribute to variability in biomarker assessment, propose areas for alignment in the field, & provide regulatory process insights. bit.ly/49f2pOu

The @4DPath team shares warm wishes for a joyous holiday season and happy New Year! In this season of gratitude, we want to extend a heartfelt thank you for being part of our journey. #HappyHolidays #HappyNewYear

.@4DPath recently had the honor of participating in a Friends of @CancerResrch panel alongside other industry leaders to discuss the promise of #computationalpathology in #oncology #drugdevelopment & clinical care. Learn more in the white paper. friendsofcancerresearch.org/…

Meet with @4DPath today @ the #SABCS23 Poster Session 5 from 12:00–2:00 PM CT, where we will present our work on predicting recurrence & survival in #breastcancer using 4D Path’s QPOR platform. sabcs.org/ #cancerdiagnostics

Visit @4DPath’s poster session @ #SABCS23 on 12/8 from 12:00–2:00 PM CT to learn about predicting recurrence & survival in breast cancer using 4D Path’s QPOR platform. Access the agenda. sabcs.org/ #digitalpathology #breastcancer

ICYMI: @4DPath recently published an article in @MedicalLabMLO examining advances in computational #digitalpathology that hold the promise of automating H&E image-based detection & prognostic evaluation of #breastcancers. Find out more on our website. 4dpath.com/advances-in-digit…

.@4DPath is pleased to confirm membership of UK’s Leeds Teaching Hospitals NHS Trust Innovation Pop-Up. Visit our website to learn more. 4dpath.com/4d-path-confirms-…

Read @4DPath's new @MedicalLabMLO article about advances in computational #digitalpathology that hold the promise of automating H&E image-based detection & prognostic evaluation of #breastcancers. mlo-online.com/disease/cance… #BreastCancerAwarenessMonth

Attend our #2023NSHConvention poster session, “Automated Robust Image Analysis Qualifying H&E Staining Adequacy with Varying Hematoxylin & Eosin Incubation Times,” today @ 12:00 PM EDT to hear new data from 4D Path, Evident Scientific & Sakura Finetek USA. 4dpath.com/4d-path-to-share-…

.@4DPath to share new data @ NSH Meeting in collaboration with Evident Scientific & Sakura Finetek USA. Read the press release & attend our poster session this Monday, Sept. 11 @ 12:00 PM EDT @ the #2023NSHConvention to learn more. 4dpath.com/4d-path-to-share-… #NSHSC #digitalpathology

This #NWHW, we recognize the role of reliable #cancer diagnosis in improving patient outcomes. That's why we're dedicated to empowering a more accurate, efficient approach to cancer diagnosis & treatment. Together, let's continue to better #womenshealth! #NationalWomensHealthWeek

.@4DPath works with many fine laboratory professionals, including Leeds Teaching Hospitals NHS Trust Biomedical Scientist Dildar Rathore, who leverage technology to improve healthcare processes & deliver the best patient care & pathways. #MLPW23 #LabWeek2023 @LeedsHospitals

On #WorldHealthDay we reflect on the promise of science & technology innovation in healthcare. By supporting clinical research & new evidence-based #digitalhealth technologies, we aim to democratize & accelerate access to #precisionmedicine to empower equitable #HealthForAll.

ICYMI: @4DPath/@UniversityLeeds & patient advocates authored an article in @pathologistmag addressing the role of public & #patientengagement in ensuring the research/clinical adoption of new #AI & related technologies. Learn more: 4dpath.com/targeting-the-for….

Visit us @ #USCAP2023 Exhibit Hall B today from 1:00-4:30 PM for our poster session, which will provide an overview of automated, ancillary test-free BRAF/NRAS mutational status prediction from digitized whole slide images of H&E-stained malignant melanomas. #DigitalPathology

.@4DPath is looking forward to presenting our poster, “Automated, Ancillary Test-Free BRAF/NRAS Mutational Status Prediction from Digitized Whole Slide Images of H&E-Stained Malignant Melanomas,” @ #USCAP2023. Attend on 3/14 from 1:00-4:30 PM in Exhibit Hall B to learn more.

.@4DPath/@UniversityLeeds joined forces with patient advocates to author an article about the importance of public & #patientengagement in cutting-edge medical advances, including innovations in #histopathology. Read it in @pathologistmag: thepathologist.com/subspecia…. #diagnostics

The State of the Union Address highlighted the #CancerMoonshot goal to significantly cut the #cancer death rate. @4DPath is optimistic about the role science & technology innovation can play to support this effort for the betterment of patients worldwide. #EndCancerAsWeKnowIt

#WorldCancerDay focuses on the importance of uniting our voices and taking action to create change and #CloseTheCareGap in the fight against #cancer. At @4DPath, we commend this effort and the pursuit to establish a future focused on better, more equitable cancer care for all!

Connect with @4DPath @ #PMWC23 to learn about our pan-cancer diagnostic & #precisiononcology platform, & its potential to help improve the diagnostic accuracy of #cancer solely from digitized histopathology images obtained via biopsies or resections. 4dpath.com/